Aditxt (ADTX) Competitors $1.04 +0.01 (+0.97%) Closing price 03:59 PM EasternExtended Trading$1.06 +0.02 (+2.40%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADTX vs. HOOK, BCDA, PRTG, IBIO, SNSE, BFRI, SNGX, APRE, DWTX, and RNAZShould you be buying Aditxt stock or one of its competitors? The main competitors of Aditxt include HOOKIPA Pharma (HOOK), BioCardia (BCDA), Portage Biotech (PRTG), iBio (IBIO), Sensei Biotherapeutics (SNSE), Biofrontera (BFRI), Soligenix (SNGX), Aprea Therapeutics (APRE), Dogwood Therapeutics (DWTX), and TransCode Therapeutics (RNAZ). These companies are all part of the "pharmaceutical products" industry. Aditxt vs. Its Competitors HOOKIPA Pharma BioCardia Portage Biotech iBio Sensei Biotherapeutics Biofrontera Soligenix Aprea Therapeutics Dogwood Therapeutics TransCode Therapeutics Aditxt (NASDAQ:ADTX) and HOOKIPA Pharma (NASDAQ:HOOK) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation. Do analysts rate ADTX or HOOK? HOOKIPA Pharma has a consensus target price of $4.50, suggesting a potential upside of 417.24%. Given HOOKIPA Pharma's stronger consensus rating and higher probable upside, analysts clearly believe HOOKIPA Pharma is more favorable than Aditxt.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aditxt 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00HOOKIPA Pharma 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is ADTX or HOOK more profitable? HOOKIPA Pharma has a net margin of -785.66% compared to Aditxt's net margin of -206,431.38%. HOOKIPA Pharma's return on equity of -120.09% beat Aditxt's return on equity.Company Net Margins Return on Equity Return on Assets Aditxt-206,431.38% -316.98% -80.88% HOOKIPA Pharma -785.66%-120.09%-77.14% Does the media refer more to ADTX or HOOK? In the previous week, Aditxt had 2 more articles in the media than HOOKIPA Pharma. MarketBeat recorded 2 mentions for Aditxt and 0 mentions for HOOKIPA Pharma. HOOKIPA Pharma's average media sentiment score of 1.00 beat Aditxt's score of -0.19 indicating that HOOKIPA Pharma is being referred to more favorably in the news media. Company Overall Sentiment Aditxt Neutral HOOKIPA Pharma Positive Which has preferable earnings and valuation, ADTX or HOOK? Aditxt has higher earnings, but lower revenue than HOOKIPA Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAditxt$12.05K182.96-$34.45MN/AN/AHOOKIPA Pharma$9.35M1.13-$43.50M-$5.85-0.15 Do insiders and institutionals have more ownership in ADTX or HOOK? 15.5% of Aditxt shares are owned by institutional investors. Comparatively, 63.9% of HOOKIPA Pharma shares are owned by institutional investors. 0.0% of Aditxt shares are owned by insiders. Comparatively, 3.3% of HOOKIPA Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, ADTX or HOOK? Aditxt has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500. Comparatively, HOOKIPA Pharma has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. SummaryHOOKIPA Pharma beats Aditxt on 10 of the 14 factors compared between the two stocks. Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADTX vs. The Competition Export to ExcelMetricAditxtMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.21M$2.80B$5.82B$9.73BDividend YieldN/A1.66%3.84%4.09%P/E RatioN/A22.6131.1525.96Price / Sales182.96751.87474.77122.97Price / CashN/A173.2237.1558.38Price / Book0.185.869.116.39Net Income-$34.45M$31.83M$3.26B$265.56M7 Day Performance1.96%1.80%2.12%1.98%1 Month Performance-16.13%4.36%5.13%1.33%1 Year Performance-99.99%11.45%31.25%21.15% Aditxt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADTXAditxt0.598 of 5 stars$1.04+1.0%N/A-100.0%$2.21M$12.05K0.0060News CoverageHOOKHOOKIPA Pharma3.3865 of 5 stars$0.82-6.8%$4.50+448.4%-83.7%$10.00M$9.35M-0.14160Positive NewsHigh Trading VolumeBCDABioCardia3.7589 of 5 stars$1.68-6.1%$25.00+1,388.1%-37.6%$9.85M$60K-0.7240Positive NewsPRTGPortage Biotech0.9261 of 5 stars$8.85-4.8%N/A+234.3%$9.75MN/A-0.216Upcoming EarningsShort Interest ↓IBIOiBio2.1301 of 5 stars$0.59-1.3%$5.00+752.8%-61.8%$9.69M$375K0.00100News CoverageGap DownSNSESensei Biotherapeutics4.3241 of 5 stars$7.52-1.8%$55.00+631.9%-35.9%$9.65MN/A-0.3540BFRIBiofrontera2.7932 of 5 stars$0.92-3.1%$2.75+199.9%-26.2%$9.60M$37.32M-0.4170Gap UpSNGXSoligenix2.1621 of 5 stars$2.44-15.9%$6.00+145.9%-24.7%$9.47M$120K-0.5720Gap DownAPREAprea Therapeutics3.6218 of 5 stars$1.70-0.1%$15.50+812.3%-58.5%$9.40M$1.50M-0.727DWTXDogwood Therapeutics1.861 of 5 stars$4.77-2.5%$10.00+109.6%N/A$9.35MN/A-0.265News CoverageAnalyst RevisionRNAZTransCode Therapeutics1.9785 of 5 stars$10.99+5.8%$280.00+2,447.8%-99.9%$8.66MN/A0.009Positive NewsGap Down Related Companies and Tools Related Companies HOOKIPA Pharma Alternatives BioCardia Alternatives Portage Biotech Alternatives iBio Alternatives Sensei Biotherapeutics Alternatives Biofrontera Alternatives Soligenix Alternatives Aprea Therapeutics Alternatives Dogwood Therapeutics Alternatives TransCode Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADTX) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access